In the wake of persistent drug shortages that compromise patient care and safety, the Biden administration and Congress have proposed policies to strengthen the pharmaceutical supply chain. Using authorities under both Medicare and Medicaid, these measures include encouraging hospitals to maintain essential medication stocks and introducing incentives tied to drug purchasing practices. Read on as we delve into these proposals and provide insights into the potential direction of future federal policies.
For more on this topic, listen to our Health Policy Breakroom podcast.
